title: The occurrence of acute lymphoblastic leukemia shortly after the cessation of human growth hormone therapy.
abstract: We encountered a case of a 21-year-old man who had developed acute lymphoblastic leukemia (ALL) shortly after the cessation of approximately six years' human growth hormone treatment for pituitary dwarfism. The patient had also been treated with thyroid preparations and methylandrostanolone, a kind of anabolic steroid. Factors relating to the onset of ALL in this case are discussed.
authors.affiliation: Department of Pediatrics, Nagoya University School of Medicine.
authors.forename: M
authors.initials: M
authors.lastname: Ogawa
authors.forename: O
authors.initials: O
authors.lastname: Mori
authors.forename: T
authors.initials: T
authors.lastname: Kamijo
authors.forename: H
authors.initials: H
authors.lastname: Tomita
authors.forename: T
authors.initials: T
authors.lastname: Yazawa
authors.forename: K
authors.initials: K
authors.lastname: Miwa
authors.forename: K
authors.initials: K
authors.lastname: Tsukidate
authors.forename: M
authors.initials: M
authors.lastname: Ogura
authors.forename: R
authors.initials: R
authors.lastname: Ohno
mesh_terms: D002648:Child; D004393:Dwarfism, Pituitary / Q000188:drug therapy; D013006:Growth Hormone / Q000009:adverse effects*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000209:etiology*; D008297:Male
chemical_list: D013006:Growth Hormone